Relay Therapeutics (RLAY) SVF Pauling (10% Owner) Sells 6M Shares

What Happened
SVF Pauling (Cayman) Ltd, identified as a 10% owner of Relay Therapeutics (RLAY), sold 6,000,000 shares on 2026-08-25 at $19.40 per share, for proceeds of $116,400,000. The filing lists the transaction as a sale (open market or private sale). This was a disposition by an institutional holder rather than an executive insider; sales are often routine portfolio or fund-management activity and do not necessarily signal company-specific views.

Key Details

• Transaction date and price: 2026-08-25 — 6,000,000 shares sold at $19.40 each.
• Total proceeds: $116,400,000.
• Shares owned after transaction: not specified in the provided filing details.
• Filing date: 2026-08-28 (filed three days after the trade). Form 4s are typically due within two business days, so this filing appears later than the usual window.
• Footnote: Securities are held of record by SVF Pauling (Cayman) Limited, a wholly owned subsidiary of SoftBank Vision Fund (AIV M2) L.P. SB Investment Advisers (UK) Ltd (SBIA UK) is the appointed AIFM and is exclusively responsible for acquisition, voting, disposal and other investment decisions for AIV M2’s holdings.

Context
This was an institutional sale by a 10% owner (SoftBank Vision Fund vehicle) rather than an individual officer or director. Institutional dispositions can reflect fund rebalancing, liquidity needs, or other portfolio-level decisions; they are not direct statements about management sentiment.